PharVision Advisers, LLC
- SEC CIK
- 0001898824
- Latest filing
- Aug 11, 2026
MYGN holding history
Myriad Genetics Inc in every 13F filed by PharVision Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MYGN overviewAll 13F holders of MYGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 16,449
- Value
- $93.9K
- % of portfolio
- 1.8%
- Quarters held
- 2
- Since Q4 2025